interferon
ifn
induc
antivir
state
cell
result
alter
pattern
level
parainfluenza
viru
type
transcript
protein
studi
report
ifnstimul
gene
protein
tetratricopeptid
repeat
primarili
respons
effect
ifn
shown
treat
cell
ifn
infect
result
increas
viru
transcript
overal
decreas
viru
protein
synthesi
obviou
decreas
overal
level
cellular
protein
synthesi
infect
cell
treat
ifn
result
suggest
select
inhibit
translat
viral
mrna
conclus
support
vitro
translat
studi
previou
work
shown
restrict
replic
virus
lack
activ
enzym
methyl
group
ribos
sugar
structur
mrna
howev
data
current
studi
strongli
suggest
mrna
methyl
group
thu
select
inhibit
translat
mrna
yet
unrecogn
mechan
also
shown
primarili
respons
ifninduc
inhibit
parainfluenza
viru
type
previous
known
simian
viru
member
genu
rubulaviru
subfamili
paramyxovirina
famili
paramyxovirida
lamb
park
like
paramyxovirus
envelop
viru
nonseg
negativesens
rna
genom
base
seven
tandemli
link
gene
encod
eight
protein
rna
genom
encod
end
nucleo
np
phospho
p
v
matrix
fusion
f
small
hydrophob
sh
haemagglutininneuraminidas
hn
larg
l
protein
viral
rna
synthesi
initi
close
end
genom
antigenom
rna
transcript
viral
polymeras
recogn
genestart
genestop
sequenc
genom
rna
result
gener
individu
mrna
also
cap
polyadenyl
viral
polymeras
failur
polymeras
reiniti
downstream
genestart
site
disengag
polymeras
genom
result
transcript
gradient
np
gene
transcrib
frequent
l
gene
least
second
gene
v
p
gene
encod
p
v
protein
use
rna
edit
mechan
replic
polymeras
must
ignor
genestart
genestop
signal
make
fulllength
copi
either
genom
antigenom
templat
negativestrand
rna
virus
polymeras
replic
transcrib
nake
rna
rather
use
ribonucleoprotein
complex
templat
gener
review
molecular
biolog
paramyxovirsu
see
lamb
park
extens
recent
review
see
park
et
al
like
virus
surviv
natur
circumv
least
partial
interferon
ifn
respons
randal
goodbourn
ifn
respons
trigger
viru
infect
result
gener
molecul
dsrna
display
molecular
signatur
term
pathogenassoci
molecular
pattern
pamp
found
uninfect
cell
recogn
cellular
receptor
term
pattern
recognit
receptor
prr
kumar
et
al
two
import
cytoplasm
prr
detect
pamp
produc
rna
virus
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
gene
rigi
preferenti
recogn
uncap
rna
molecul
short
stretch
dsrna
whilst
recogn
longer
molecul
dsrna
need
triphosphoryl
schmidt
et
al
upon
bind
appropri
ligand
rigi
initi
signal
cascad
result
secret
ifnb
infect
cell
secret
ifn
act
autocrin
paracrin
manner
upregul
express
hundr
cellular
gene
mani
direct
indirect
antivir
activ
randal
goodbourn
number
strategi
minim
effect
ifn
respons
encod
ifn
antagonist
v
protein
limit
product
ifn
block
ifn
signal
review
ramachandran
horvath
v
protein
limit
ifn
induct
interact
directli
prevent
bind
dsrna
thu
prevent
activ
ifn
induct
cascad
andrejeva
et
al
child
et
al
furthermor
whilst
v
protein
bind
directli
rigi
indirectli
inhibit
rigi
bind
laboratori
genet
physiolog
protein
helicas
relat
rigi
stabil
interact
rigi
therebi
inhibit
rigi
child
et
al
addit
act
competit
inhibitor
tankbind
kinas
reduc
abil
phosphoryl
ifn
regulatori
factor
lu
et
al
v
protein
also
block
ifn
signal
target
signal
transduc
activ
transcript
proteasomemedi
degrad
didcock
et
al
mechan
requir
act
bridg
cellular
ubiquitin
ligas
heterodim
parisien
et
al
preciou
et
al
addit
mechan
tightli
control
transcript
replic
genom
therebi
limit
product
pamp
may
activ
ifn
induct
cascad
park
et
al
inde
recent
evid
suggest
success
pamp
activ
ifn
induct
cascad
produc
normal
viru
replic
killip
et
al
killip
et
al
instead
pamp
activ
ifn
respons
produc
primarili
defect
interf
particl
gener
aberr
viru
replic
chen
et
al
killip
et
al
despit
ifnevas
mechan
strategi
abil
circumv
ifn
respons
absolut
wit
observ
plaqu
significantli
larger
cell
produc
andor
respond
ifn
compar
ifncompet
cell
carlo
et
al
young
et
al
plaqu
develop
rather
infect
cell
produc
ifn
induc
antivir
state
surround
uninfect
cell
chen
et
al
whilst
replic
sever
restrict
cell
ifninduc
antivir
state
carlo
et
al
nevertheless
viru
manag
target
proteasomemedi
degrad
didcock
et
al
preciou
et
al
consequ
absenc
continu
stimul
ifn
cell
maintain
antivir
state
indefinit
within
h
viru
manag
establish
normal
pattern
viru
replic
carlo
et
al
studi
effect
ifn
replic
develop
system
cell
produc
ifn
respond
ifn
infect
isol
term
block
ifn
signal
fail
target
proteasomemedi
degrad
chatziandr
et
al
thu
possibl
infect
ifncompromis
cell
allow
viru
establish
normal
replic
pattern
variou
time
postinfect
pi
add
ifn
cultur
medium
monitor
effect
ifn
viru
replic
protein
synthesi
carlo
et
al
use
system
shown
previous
addit
ifn
cell
activ
synthes
protein
alter
pattern
viru
mrna
transcript
induc
mark
reduct
viru
protein
synthesi
particularli
hn
protein
carlo
et
al
use
system
show
myxoviru
mxa
protein
kinas
r
pkr
oligoadenyl
synthetas
oa
rnase
l
respons
alter
viru
protein
synthesi
observ
follow
ifn
treatment
present
evid
ifnstimul
gene
protein
tetratricopeptid
repeat
primarili
respons
observ
effect
ifn
transcript
protein
synthesi
primarili
respons
ifninduc
alter
pattern
protein
synthesi
shown
previous
pkr
oa
mx
major
ifninduc
activ
limit
replic
attempt
identifi
ifnstimul
gene
isg
primarili
respons
ifninduc
inhibit
cell
transient
transfect
plasmid
permit
constitut
express
ifninduc
protein
viperin
cell
subsequ
infect
variant
unabl
block
ifn
signal
chatziandr
et
al
h
pi
cell
fix
stain
viral
np
overexpress
isg
overexpress
viperin
obviou
effect
level
np
p
data
shown
contrast
shown
fig
cell
transient
express
neg
np
next
knock
express
endogen
human
gene
cell
use
small
hairpin
rna
shrna
fig
avail
jgv
onlin
cell
use
engin
previous
express
bovin
viral
diarrhea
viru
bvdv
n
pro
protein
constitut
render
unabl
produc
ifn
although
still
abl
respond
exogen
ad
ifn
hilton
et
al
control
cell
ie
express
bvdvn
pro
infect
strain
normal
pattern
viru
protein
synthesi
observ
fig
lane
howev
viru
protein
synthesi
dramat
reduc
cell
pretreat
ifn
fig
lane
strike
contrast
nearnorm
pattern
viru
protein
synthesi
observ
ifntreat
cell
impair
express
fig
compar
lane
also
examin
effect
treat
cell
ifn
subsequ
infect
treatment
control
cell
ifn
h
pi
reduc
overal
level
viru
protein
synthesi
particular
express
hn
protein
compar
lane
fig
posit
protein
highlight
asterisk
total
cell
extract
cell
infect
subsequ
treat
ifn
nearnorm
pattern
viru
protein
synthesi
observ
compar
lane
fig
knockdown
cell
ie
without
express
bvdvn
pro
produc
respond
ifn
thu
begin
inhibit
prior
addit
exogen
ifn
cultur
medium
also
restor
nearnorm
pattern
viru
protein
synthesi
even
exogen
ifn
ad
cultur
medium
fig
similar
result
also
obtain
cell
fig
result
clearli
demonstr
primarili
respons
ifninduc
inhibit
viru
protein
synthesi
also
strike
effect
ifn
level
viru
protein
synthesi
pro
cell
due
gener
shutdown
protein
synthesi
level
host
protein
synthesi
similar
ifn
pretreat
posttreat
untreat
cell
fig
fig
primarili
respons
ifninduc
chang
cpi
protein
synthesi
pro
control
cell
pro
cell
treat
ifn
h
prior
infect
high
moi
cpi
ifn
pretreat
treat
ifn
h
pi
ifn
posttreat
h
pi
cell
radioact
label
l
methionin
h
viral
protein
immunoprecipit
total
cell
extract
lefthand
panel
immunoprecipit
righthand
panel
separ
electrophoresi
polyacrylamid
gel
label
protein
visual
use
phosphoimag
posit
protein
total
cell
extract
indic
asterisk
sampl
total
cell
extract
correspond
sampl
lane
also
immunoblot
presenc
bottom
panel
induc
ifn
bactin
next
examin
whether
inhibit
viru
protein
synthesi
due
inhibit
viru
transcript
translat
first
undertook
timecours
studi
viru
mrna
accumul
absenc
ifn
respons
control
cell
analysi
quantit
pcr
qpcr
use
measur
rel
amount
np
pv
hn
l
viral
mrna
control
cell
result
analysi
fig
show
highest
mrna
level
occur
around
h
pi
gener
pattern
time
point
examin
clear
gradat
mrna
level
np
p
hn
l
gene
observ
l
mrna
least
abund
expect
gradient
relat
order
gene
within
viru
genom
consist
predict
dissoci
viru
rna
polymeras
templat
except
mrna
alway
significantli
less
abund
hn
mrna
despit
proxim
posit
gene
promot
discuss
control
cell
treat
ifn
h
prior
infect
level
viral
mrna
measur
h
pi
signific
decreas
observ
amount
viral
mrna
fig
howev
surprisingli
treat
cell
ifn
h
infect
increas
rather
decreas
amount
viral
mrna
greatest
increas
note
amount
l
mrna
suggest
less
chanc
polymeras
disengag
templat
cell
treat
ifn
infect
condit
level
mrna
higher
hn
mrna
fig
contrast
control
cell
treat
bvdvn
pro
cell
ifn
either
prior
infect
significantli
alter
either
pattern
level
viru
transcript
accumul
increas
viral
mrna
level
observ
control
cell
treat
ifn
infect
reflect
level
viru
protein
synthes
significantli
reduc
respons
ifn
fig
condit
mark
reduct
synthesi
cellular
protein
data
suggest
ifn
action
induc
specif
block
translat
viral
mrna
investig
mrna
isol
control
cell
h
pi
translat
cellfre
rabbit
reticulocyt
lysat
order
compar
pattern
viru
protein
synthesi
cell
parallel
cultur
also
label
methionin
complet
contrast
decreas
viru
protein
synthesi
observ
infect
cell
obviou
increas
amount
viral
protein
made
vitro
translat
mrna
isol
cell
treat
ifn
fig
note
protein
total
cell
sampl
highlight
asterisk
consist
qpcr
data
fig
show
ifn
treatment
cell
infect
led
increas
viral
mrna
synthesi
demonstr
mrna
remain
translat
contrast
increas
vitro
translat
cellular
protein
confirm
select
block
viral
mrna
translat
control
cell
follow
ifn
treatment
taken
togeth
result
strongli
suggest
select
inhibit
translat
viral
mrna
suggest
recent
ifit
famili
protein
recogn
inhibit
translat
viral
mrna
cap
act
mechan
host
cell
distinguish
self
nonself
mrna
viru
infect
daffi
et
al
although
polymeras
predict
activ
ferron
et
al
test
whether
mrna
cap
methyl
posit
mrna
isol
mockor
control
cell
h
pi
incorpor
hlabel
methyl
group
donor
sadenosylmethionin
monitor
vitro
methyl
assay
use
vaccinia
viru
schnierl
et
al
detect
incorpor
h
observ
mrna
isol
mockinfect
cell
fig
suggest
viral
mrna
inde
addit
induc
alter
pattern
viru
protein
synthesi
ifn
also
alter
distribut
viru
protein
cell
np
protein
becom
primarili
local
cytoplasm
bodi
carlo
et
al
therefor
also
examin
distribut
np
p
protein
cell
experi
use
cell
rather
cell
give
betterqu
immunofluoresc
data
observ
fig
untreat
control
cell
ie
constitut
express
bvdvn
pro
np
distribut
primarili
throughout
cytoplasm
whilst
cell
treat
exogen
ifn
np
locat
primarili
cytoplasm
bodi
mark
contrast
follow
treatment
cell
ifn
distribut
np
distribut
primarili
throughout
h
pi
mrna
isol
parallel
cultur
subject
vitro
translat
use
rabbit
reticulocyt
lysat
viral
protein
immunoprecipit
prior
separ
electrophoresi
gradient
polyacrylamid
gel
label
protein
visual
use
phosphoimag
posit
protein
total
cell
sampl
indic
asterisk
cytoplasm
resembl
pattern
observ
control
cell
treat
ifn
although
major
isg
inhibit
isg
also
contribut
antivir
activ
ifn
investig
influenc
product
infecti
viru
amount
infecti
viru
cultur
medium
control
cell
determin
day
infect
fig
pretreat
control
cell
ifn
reduc
titr
log
pfu
ml
contrast
ifn
pretreat
knockdown
cell
reduc
titr
approxim
tenfold
result
clearli
show
whilst
major
contributor
ifninduc
inhibit
growth
isg
must
also
contribut
induct
ifninduc
antivir
state
conclus
support
observ
whilst
knockdown
facilit
plaqu
format
cell
normal
support
plaqu
plaqu
form
larg
observ
control
cell
ie
express
bvdvn
pro
fig
although
encod
power
ifn
antagonist
v
protein
limit
ifn
induct
block
ifn
signal
abil
circumv
ifn
respons
absolut
thu
plaqu
develop
virusinfect
cell
produc
ifn
induc
antivir
state
uninfect
cell
surround
plaqu
therebi
slow
spread
viru
carlo
et
al
chen
et
al
set
understand
detail
ifn
induc
antivir
state
identifi
isg
inhibit
viru
replic
result
present
demonstr
although
isg
contribut
minor
degre
ifninduc
antivir
state
remark
primarili
respons
observ
ifninduc
alter
transcript
protein
synthesi
member
famili
protein
whose
express
strongli
induc
low
basal
level
ifn
activ
review
fensterl
sen
famili
member
structur
featur
common
contain
sever
tetratricopeptid
repeat
repres
helixturnhelix
motif
mediat
varieti
proteinprotein
interact
beststudi
cellular
function
inhibit
translat
initi
guo
et
al
terenzi
et
al
mediat
bind
eukaryot
initi
factor
addit
gener
inhibit
mrna
translat
suggest
recent
specif
inhibit
translat
viral
mrna
appropri
cap
eukaryot
host
mrna
modifi
end
addit
nontempl
guanosin
residu
methyl
addit
ribos
ring
first
one
two
templat
base
whilst
guanosin
increas
translat
effici
reason
ribos
sugar
unclear
furuichi
shatkin
howev
recent
work
suggest
lack
methyl
ribos
might
allow
cell
distinguish
self
nonself
rna
daffi
et
al
pichlmair
et
al
et
al
avoid
recognit
suggest
virus
replic
cytoplasm
evolv
methyl
viral
mrna
cap
structur
west
nile
viru
mous
coronaviru
vaccinia
viru
mutant
lack
activ
enhanc
sensit
ifn
antivir
activ
protein
et
al
also
report
recent
bind
uncap
triphosphoryl
rna
found
end
genom
antigenom
rna
rna
virus
well
end
viral
transcript
pichlmair
et
al
howev
relationship
properti
abil
preferenti
inhibit
translat
mrna
cap
structur
lack
group
still
therefor
triphosphoryl
unclear
result
present
show
select
inhibit
mrna
translat
inabl
detect
mrna
within
sensit
test
suggest
select
inhibit
unlik
due
defici
cap
although
rule
possibl
cell
may
contain
small
amount
mrna
may
activ
regard
note
whilst
viral
polymeras
absolut
conserv
residu
enzym
ferron
et
al
like
newcastl
diseas
viru
parainfluenza
viru
type
mump
viru
simian
viru
alanin
instead
first
glycin
posit
sendai
viru
l
glycinerich
motif
methyltransferas
domain
member
order
mononegaviral
may
influenc
effici
murphi
et
al
well
select
inhibit
translat
mrna
also
clear
affect
viru
transcript
support
data
present
use
northern
blot
analysi
examin
effect
ifn
transcript
mrna
vero
cell
produc
respond
ifn
report
increas
np
p
mrna
transcript
follow
ifn
treatment
pi
carlo
et
al
activ
affect
viru
transcript
remain
establish
may
inhibit
viral
protein
synthesi
lead
indirectli
alter
pattern
viru
transcript
exampl
chang
ratio
particular
viru
protein
viral
protein
eg
v
protein
rel
short
half
life
fearn
et
al
neg
regul
viral
rna
synthesi
lin
et
al
result
increas
viru
transcript
andor
alter
process
viral
polymerasetranscript
complex
altern
may
directli
interact
viral
polymeras
alter
activ
regard
note
bind
inactiv
viral
helicas
human
papillomaviru
essenti
viral
dna
replic
terenzi
et
al
previou
studi
use
northern
blot
analysi
examin
pattern
transcript
vero
cell
treat
ifn
pi
well
note
increas
level
np
p
mrna
also
note
signific
decreas
level
fulllength
hn
mrna
carlo
et
al
time
specul
either
polymeras
like
disengag
templat
proceed
genom
cell
treat
ifn
ifn
somehow
affect
stabil
hn
mrna
given
shown
ifntreat
control
cell
increas
level
viral
mrna
suggest
latter
explan
may
correct
altern
may
differ
effect
ifn
vero
cell
also
suggest
previous
ifn
may
modul
influenc
establish
mainten
persist
infect
favour
format
viru
cytoplasm
bodi
shown
contain
genom
rna
may
site
viru
establish
quiescent
infect
hide
innat
intracellular
antivir
respons
adapt
immun
respons
carlo
et
al
chatziandr
et
al
fearn
et
al
respect
interest
mark
reduct
viral
protein
synthes
cell
either
preor
posttreat
ifn
encod
protein
downstream
p
gene
particular
protein
whilst
synthesi
np
p
although
inhibit
remain
rel
high
reason
appar
differ
effect
ifn
rel
inhibit
differ
viral
protein
remain
unclear
may
simpli
reflect
stabil
protein
np
p
stabl
hn
rel
unstabl
nevertheless
consequ
chang
rel
level
viral
protein
ie
increas
rel
amount
np
p
compar
viru
protein
might
favour
format
cytoplasm
bodi
inde
fact
knockdown
prevent
format
inclus
bodi
induc
coexpress
np
p
cell
line
lead
format
larg
cytoplasm
aggreg
absenc
ifn
respons
preciou
et
al
suggest
balanc
viral
protein
synthes
influenc
format
viral
cytoplasm
bodi
rather
induct
specif
cellular
isg
drive
format
cell
virus
ifn
vero
cell
respect
deriv
grown
monolay
cm
tissuecultur
flask
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
uc
need
cell
treat
human
recombin
ifn
roferona
roch
u
ml
isol
grown
titrat
vero
cell
prepar
radiolabel
antigen
extract
immunoprecipit
sdspage
methodolog
use
describ
elsewher
carlo
et
al
briefli
cell
mock
infect
infect
h
pi
treat
ifn
left
untreat
h
metabol
label
h
l
methionin
ci
mmol
mp
biomed
label
cell
lyse
immunoprecipit
buffer
sonic
centrifug
min
g
remov
solid
materi
immunocomplex
form
incub
solubl
antigen
protein
gsepharos
sigma
precoupl
mix
mab
viral
protein
np
p
hn
protein
immunocomplex
dissoci
heat
min
uc
analys
sdspage
gel
fix
stain
dri
resolv
band
visual
phosphorimag
analysi
plasmid
gener
cell
express
shrna
mammalian
express
vector
contain
fulllength
haemagglutinin
ha
tag
gene
kind
gift
dr
f
weber
institut
virolog
philipp
univers
marburg
germani
lentiviru
vector
use
express
shrna
sequenc
base
describ
everett
et
al
deriv
vector
express
blasticidin
resist
gene
plkoblast
obtain
dr
r
everett
cvr
univers
glasgow
uk
doublestrand
oligonucleotid
correspond
target
sequenc
clone
plkoblast
target
sequenc
human
region
region
li
et
al
method
use
isol
lentiviru
stock
describ
previous
hilton
et
al
lentivirusinfect
cell
select
blasticidin
mg
ml
maintain
week
medium
contain
blasticidin
immunofluoresc
immunofluoresc
analysi
cell
grown
mm
diamet
coverslip
gener
scientif
co
individu
well
sixwel
plate
cell
transient
transfect
plasmid
encod
hatag
h
posttransfect
cell
infect
differ
virus
h
pi
monolay
cell
coverslip
incub
fix
solut
formaldehyd
pb
min
room
temperatur
permeabil
sucros
pb
min
wash
three
time
pb
contain
fc
detect
protein
interest
cell
monolay
incub
ml
appropri
dilut
primari
antibodi
h
infect
mab
np
p
protein
use
name
respect
randal
et
al
detect
overexpress
antiha
rabbit
polyclon
antibodi
sigma
use
subsequ
incub
primari
antibodi
cell
wash
sever
time
fc
pb
incub
h
secondari
texa
redconjug
goat
antimous
igg
viral
protein
fitcconjug
goat
antirabbit
igg
detect
sera
lab
qpcr
total
cellular
rna
extract
infect
cell
use
trizol
invitrogen
two
microgram
rna
subsequ
use
rtpcr
fragment
bp
amplifi
primer
np
p
hn
l
bactin
use
refer
gene
primer
sequenc
np
forward
revers
p
forward
revers
forward
revers
hn
forward
revers
l
forward
revers
bactin
forward
revers
plot
valu
mrna
express
quantiti
gene
interest
rel
quantiti
refer
gene
obtain
normal
rel
express
valu
sampl
perform
duplic
qpcr
plate
two
separ
experi
nontempl
sampl
nonrevers
transcriptas
sampl
analys
routin
neg
control
data
collect
use
realtim
pcr
system
appli
biosystem
vitro
methyl
assay
poli
contain
rna
isol
mockor
cell
oligotex
direct
mrna
mini
kit
accord
manufactur
instruct
qiagen
vitrotranscrib
model
rna
encod
np
mous
hepat
coronaviru
gener
use
ribomax
express
larg
scale
rna
product
system
promega
cap
ad
use
scriptcap
cap
system
accord
manufactur
recommend
cellscript
reaction
carri
describ
previous
et
al
briefli
ng
vitrotranscrib
ng
poli
contain
rna
deriv
virusinfect
cell
correspond
amount
poli
contain
rna
uninfect
cell
incub
h
uc
scriptcap
cellscript
presenc
mm
sadenosylmethionin
mm
hlabel
sadenosylmethionin
ci
mmol
perkin
elmer
reaction
purifi
sigmaspin
postreact
cleanup
column
sigmaaldrich
eluat
mix
ml
ultima
gold
scintil
fluid
measur
h
incorpor
packard
tricarb
liquid
scintil
counter
perkin
elmer
